1986
DOI: 10.1148/radiology.160.1.3459211
|View full text |Cite
|
Sign up to set email alerts
|

Granulocytic sarcoma of the brain: a case report and review of the literature.

Abstract: Granulocytic sarcoma (chloroma), a rare tumor usually associated with myelogenous leukemia, is capable of invading the meninges or brain parenchyma. Radiologic findings in a case of granulocytic sarcoma of the brain, as well as those in 11 previously reported cases of intracranial leukemic masses, are interpreted. On computed tomographic scans, the lesions can appear isodense or hyperdense, edema and necrosis are variable, and there is uniform enhancement following intravenous administration of contrast materi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
28
0
5

Year Published

1990
1990
2018
2018

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 59 publications
(35 citation statements)
references
References 0 publications
2
28
0
5
Order By: Relevance
“…Allogeneic BMT is often used for the treatment of AML, acute lymphoblastic leukemia (ALL), and chronic myeloid leukemia (CML). Myeloid sarcoma is a rare complication observed in AML patients after BMT and may be the first sign of relapse 4) ; myeloid sarcoma may also precede the onset of systemic disease 3,11) . In a 10-year survey conducted by the European BMT Registry, the incidence rate of myeloid sarcoma associated with AML was 0.65% 4) .…”
Section: Resultsmentioning
confidence: 99%
“…Allogeneic BMT is often used for the treatment of AML, acute lymphoblastic leukemia (ALL), and chronic myeloid leukemia (CML). Myeloid sarcoma is a rare complication observed in AML patients after BMT and may be the first sign of relapse 4) ; myeloid sarcoma may also precede the onset of systemic disease 3,11) . In a 10-year survey conducted by the European BMT Registry, the incidence rate of myeloid sarcoma associated with AML was 0.65% 4) .…”
Section: Resultsmentioning
confidence: 99%
“…The exact pathogenesis of granulocytic sarcoma is still unclear and it may be the first sign of relapse after bone marrow transplantation or may precede the onset of systemic disease (6,7). Central nervous system (CNS) leukemia is believed to develop as a result of hematogenous spread or direct extension from involved cranial bone marrow.…”
Section: Discussionmentioning
confidence: 99%
“…GS is an uncommon disease, clinically presenting in 2.9% of all acute leukemias (1,2). It is strongly associated with AML or the accelerated phase of CML.…”
Section: Discussionmentioning
confidence: 99%